What's happening in the industry

FDA approval brings first gene therapy to the United States read on...

Gilead to buy Kite for promising cancer therapies in $12 billion deal read on...

A cancer conundrum: too many drug trials, too few patients read on...

Exosome Diagnostics, CareFirst partner to speed up coverage for diagnostic tests read on...

Cancer Treatment Centers of America, Foundation Medicine partner on precision medicine education initiative read on...

Bristol-Myers Squibb's Opdivo nabs MSI-H colorectal cancer nod, but it can't match Keytruda's umbrella approval read on...

Invivoscribe releases LeukoStrat CDx FLT3 mutation assay as CE-marked IVD assay kit read on...

Direct detection of early-stage cancers using circulating tumor DNA read on...

OmniSeq and LabCorp sign exclusive distribution agreement and Series B funding commitment read on...

QIAGEN and Clinical Genomics partner on liquid biopsies to monitor patients for recurrence of colorectal cancer read on...

New Pathology Atlas maps genes in cancer to accelerate progress in personalized medicine read on...

FDA approves Idhifa (Enasidenib) for acute myeloid leukemia read on...

Concept paper on development and lifecycle of personalised medicines and companion diagnostics read on...

FDA allows WIN Consortium to proceed with targeted tri-therapy clinical trial in first line treatment of metastatic non small cell lung cancer read on...

Biocept and UT Southwestern Medical Center announce clinical study to profile and monitor non-small cell lung cancer patients with ALK rearrangements read on...

Addario Lung Cancer Medical Institute, Champions Oncology and Motivated Patients announce a research collaboration and launch of a patient driven clinical study in ROS1 positive cancer read on...

Systemic therapy for Stage IV non–small-cell lung cancer update read on...

NIH gives nod to Vibrent Health for precision medicine work read on...

Myriad’s EndoPredict receives positive coverage decisions from Anthem, Palmetto read on...

Merck update on Phase 3 Study of Keytruda in patients with previously treated recurrent or metastatic head and neck squamous cell carcinoma read on...

Alligator expands immuno-oncology collaboration with Stanford University read on...

New breast cancer blood test could improve treatment options in more serious cases read on...

NCI-COG Pediatric MATCH trial to test targeted drugs in childhood cancers read on...

AstraZeneca's Mystic cancer drug trial fails read on...

What you might have missed

Article from G2 Intelligence - Companion diagnostics driving new model for pharma-Dx partnerships
Expert Insight - Liquid biopsy: clearing the barriers to support pharma, labs and patients
Listen to our latest webinar - Moving beyond the hype: the reality of NGS in oncology today and in the future
Have you read our most downloaded Expert Insight? Mystery solved! What is the cost to develop and launch a diagnostic?